AnGes Inc AMGXF:Grey Market

RT Quote | Exchange | USD
Last | 02/26/21 EDT
9.60UNCH (UNCH)
52 week range
9.60 - 20.49

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.60
  • 52 Week High20.49
  • 52 Week High Date06/17/20
  • 52 Week Low9.60
  • 52 Week Low Date02/26/21

Key Stats

  • Market Cap1,156.78M
  • Shares Out133.06M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.60
  • 52 Week High20.49
  • 52 Week High Date06/17/20
  • 52 Week Low9.60
  • 52 Week Low Date02/26/21
  • Market Cap1,156.78M
  • Shares Out133.06M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.34
  • P/E (TTM)-28.08
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From AnGes Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to...
Ei Yamada
President
Address
7-7-15 Saito-asagi
Saito Bio-Incubator 4 Fl.
Ibaraki-shi, OSK
567-0085
Japan